Beam Therapeutics Inc. (BEAM) › Operating IncomeBeam Therapeutics Inc. (BEAM) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$75.15M2020: -$132.76M2021: -$392.46M2022: -$338.48M2023: -$176.49M2024: -$415.57M2025: -$383.69M-$383.69M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$383.69M+7.7%2024-$415.57M-135.5%2023-$176.49M+47.9%2022-$338.48M+13.8%2021-$392.46M-195.6%2020-$132.76M-76.7%2019-$75.15M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share